Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 7XP

Max Ratio

Dividend Yield

1.12 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

20.72 %

Dividend History 7XP

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.12 %
Consecutive Years 0
Forward Annual Dividend 0.080 USD
Consistent Years 0
Dividend CAGR 3Y 25.99 %
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 31.19 %
Dividend CAGR 10Y
Ex Dividend Date 11/20/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 7XP

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 7XP

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 7XP

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 7XP

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 7XP

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Organon & Co 7XP

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 7XP

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 4.04
Forward PE 5.03
Enterprise Value Revenue 1.61
Price Sales TTM 0.32
Enterprise Value EBITDA 6.52
Price Book MRQ 2.22

Organon & Co Dividends: 1.12 % Yield, History, Payment Schedule

7XP
Current price
6.12 EUR -0.082 EUR (-1.32%)
Last closed 7.27 USD
ISIN US68622V1061
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Frankfurt Exchange
Capitalization 2 004 468 224 USD
Yield for 12 month -52.78 %
1Y
3Y
5Y
10Y
15Y
7XP
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+6 403 000 000 USD

Last Year

+6 263 000 000 USD

Current Quarter

+1 602 000 000 USD

Last Quarter

+1 594 000 000 USD

Current Year

+3 715 000 000 USD

Last Year

+3 748 000 000 USD

Current Quarter

+857 000 000 USD

Last Quarter

+874 000 000 USD
EBITDA 1 688 999 936 USD
Operating Margin TTM 23.10 %
Price to Earnings 4.04
Return On Assets TTM 6.40 %
PEG Ratio
Return On Equity TTM 71.62 %
Wall Street Target Price 9.67 USD
Revenue TTM 6 301 000 192 USD
Book Value 3.49 USD
Revenue Per Share TTM
Dividend Share 0.60 USD
Quarterly Revenue Growth YOY 1.30 %
Dividend Yield 1.12 %
Gross Profit TTM 3 508 000 000 USD
Earnings per share 1.91 USD
Diluted Eps TTM 1.91 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -55.80 %
Profit Margin 7.95 %

Technical Indicators 7XP

For 52 Weeks

6.16 USD 16.80 USD
50 Day MA 8.70 USD
Shares Short Prior Month 12 151 104
200 Day MA 10.55 USD
Short Ratio 1.90
Shares Short 15 587 869
Short Percent 7.99 %